• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种单分子计数分析方法以在临床上鉴别嫌色性肾细胞癌和嗜酸细胞瘤。

Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics.

作者信息

Bin Satter Khaled, Ramsey Zach, Tran Paul M H, Hopkins Diane, Bearden Gregory, Richardson Katherine P, Terris Martha K, Savage Natasha M, Kavuri Sravan K, Purohit Sharad

机构信息

Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, 1120, 15th St., Augusta, GA 30912, USA.

Department of Pathology, Medical College of Georgia, Augusta University, 1120 15th St., Augusta, GA 30912, USA.

出版信息

Cancers (Basel). 2022 Jul 1;14(13):3242. doi: 10.3390/cancers14133242.

DOI:10.3390/cancers14133242
PMID:35805014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9265083/
Abstract

Malignant chromophobe renal cancer (chRCC) and benign oncocytoma (RO) are two renal tumor types difficult to differentiate using histology and immunohistochemistry-based methods because of their similarity in appearance. We previously developed a transcriptomics-based classification pipeline with "Chromophobe-Oncocytoma Gene Signature" (COGS) on a single-molecule counting platform. Renal cancer patients ( = 32, chRCC = 17, RO = 15) were recruited from Augusta University Medical Center (AUMC). Formalin-fixed paraffin-embedded (FFPE) blocks from their excised tumors were collected. We created a custom single-molecule counting code set for COGS to assay RNA from FFPE blocks. Utilizing hematoxylin-eosin stain, pathologists were able to correctly classify these tumor types (91.8%). Our unsupervised learning with UMAP (Uniform manifold approximation and projection, accuracy = 0.97) and hierarchical clustering (accuracy = 1.0) identified two clusters congruent with their histology. We next developed and compared four supervised models (random forest, support vector machine, generalized linear model with L2 regularization, and supervised UMAP). Supervised UMAP has shown to classify all the cases correctly (sensitivity = 1, specificity = 1, accuracy = 1) followed by random forest models (sensitivity = 0.84, specificity = 1, accuracy = 1). This pipeline can be used as a clinical tool by pathologists to differentiate chRCC from RO.

摘要

恶性嫌色细胞肾细胞癌(chRCC)和良性嗜酸性细胞瘤(RO)是两种肾肿瘤类型,由于它们外观相似,使用基于组织学和免疫组织化学的方法难以区分。我们之前在单分子计数平台上开发了一种基于转录组学的分类流程,即“嗜色细胞 - 嗜酸性细胞瘤基因特征”(COGS)。从奥古斯塔大学医学中心(AUMC)招募了肾癌患者(n = 32,chRCC = 17,RO = 15)。收集了他们切除肿瘤的福尔马林固定石蜡包埋(FFPE)块。我们为COGS创建了一个定制的单分子计数码集,以检测来自FFPE块的RNA。利用苏木精 - 伊红染色,病理学家能够正确分类这些肿瘤类型(91.8%)。我们使用UMAP(均匀流形近似和投影,准确率 = 0.97)和层次聚类(准确率 = 1.0)进行无监督学习,识别出两个与其组织学一致的聚类。接下来,我们开发并比较了四种监督模型(随机森林、支持向量机、具有L2正则化的广义线性模型和监督UMAP)。监督UMAP已显示能够正确分类所有病例(敏感性 = 1,特异性 = 1,准确率 = 1),其次是随机森林模型(敏感性 = 0.84,特异性 = 1,准确率 = 1)。该流程可作为病理学家区分chRCC和RO的临床工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df5c/9265083/f7c0e7de7668/cancers-14-03242-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df5c/9265083/d8916ed5eabd/cancers-14-03242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df5c/9265083/d6c0283c979b/cancers-14-03242-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df5c/9265083/f7c0e7de7668/cancers-14-03242-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df5c/9265083/d8916ed5eabd/cancers-14-03242-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df5c/9265083/d6c0283c979b/cancers-14-03242-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df5c/9265083/f7c0e7de7668/cancers-14-03242-g003.jpg

相似文献

1
Development of a Single Molecule Counting Assay to Differentiate Chromophobe Renal Cancer and Oncocytoma in Clinics.开发一种单分子计数分析方法以在临床上鉴别嫌色性肾细胞癌和嗜酸细胞瘤。
Cancers (Basel). 2022 Jul 1;14(13):3242. doi: 10.3390/cancers14133242.
2
Oncocytoma-Related Gene Signature to Differentiate Chromophobe Renal Cancer and Oncocytoma Using Machine Learning.基于机器学习的嗜酸细胞瘤相关基因特征鉴别肾嫌色细胞癌和嗜酸细胞瘤
Cells. 2022 Jan 15;11(2):287. doi: 10.3390/cells11020287.
3
Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.散发性具有嗜酸性细胞瘤和嫌色细胞肾细胞癌之间特征的肿瘤:全面的临床病理和基因组分析。
Hum Pathol. 2020 Oct;104:18-29. doi: 10.1016/j.humpath.2020.07.003. Epub 2020 Jul 13.
4
Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.基因组表达和单核苷酸多态性分析可区分嫌色细胞肾细胞癌和嗜酸细胞瘤。
BMC Cancer. 2010 May 12;10:196. doi: 10.1186/1471-2407-10-196.
5
Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?瘦素及其受体:能否帮助鉴别嫌色细胞型肾细胞癌与肾嗜酸细胞瘤?
Pathology. 2018 Aug;50(5):504-510. doi: 10.1016/j.pathol.2018.01.007. Epub 2018 Jun 30.
6
Diagnostic utility of amylase α-1A, MOC 31, and in renal oncocytoma versus chromophobe renal cell carcinoma.α-1A 型淀粉酶、MOC31 和 在肾嗜酸细胞瘤与嫌色性肾细胞癌中的诊断价值。
Indian J Pathol Microbiol. 2020 Jul-Sep;63(3):405-411. doi: 10.4103/IJPM.IJPM_719_19.
7
Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy.质谱成像可高精度鉴别嫌色性肾细胞癌和肾嗜酸细胞瘤。
J Cancer. 2020 Aug 21;11(20):6081-6089. doi: 10.7150/jca.47698. eCollection 2020.
8
Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.下一代测序检测嗜铬性肾细胞癌中 RB1 和 ERBB4 基因缺失:在鉴别嗜铬性肾细胞癌与肾嗜酸细胞瘤中的潜在作用。
Am J Pathol. 2018 Apr;188(4):846-852. doi: 10.1016/j.ajpath.2017.12.003. Epub 2018 Jan 31.
9
Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma.细胞角蛋白7、S100A1和小窝蛋白-1作为免疫组织化学生物标志物在鉴别嫌色性肾细胞癌与肾嗜酸细胞瘤中的应用
Transl Androl Urol. 2019 May;8(Suppl 2):S123-S137. doi: 10.21037/tau.2018.11.02.
10
Exploring Multiphoton Microscopy as a Novel Tool to Differentiate Chromophobe Renal Cell Carcinoma From Oncocytoma in Fixed Tissue Sections.探讨多光子显微镜作为一种新型工具,用于在固定组织切片中区分嫌色细胞性肾细胞癌与嗜酸细胞瘤。
Arch Pathol Lab Med. 2018 Mar;142(3):383-390. doi: 10.5858/arpa.2017-0056-OA. Epub 2017 Dec 8.

引用本文的文献

1
Insights into Urologic Cancer.泌尿系统癌症洞察
Cancers (Basel). 2023 Jun 8;15(12):3108. doi: 10.3390/cancers15123108.
2
Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma.肾透明细胞癌的诊断和预后生物标志物
Biomedicines. 2022 Nov 17;10(11):2953. doi: 10.3390/biomedicines10112953.

本文引用的文献

1
Oncocytoma-Related Gene Signature to Differentiate Chromophobe Renal Cancer and Oncocytoma Using Machine Learning.基于机器学习的嗜酸细胞瘤相关基因特征鉴别肾嫌色细胞癌和嗜酸细胞瘤
Cells. 2022 Jan 15;11(2):287. doi: 10.3390/cells11020287.
2
A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform.基于 NanoString 平台的小 B 细胞淋巴肿瘤新型诊断方法。
Mod Pathol. 2022 May;35(5):632-639. doi: 10.1038/s41379-021-00954-z. Epub 2021 Nov 20.
3
Retrospective Validation of a 168-Gene Expression Signature for Glioma Classification on a Single Molecule Counting Platform.
在单分子计数平台上对用于胶质瘤分类的168基因表达特征进行回顾性验证
Cancers (Basel). 2021 Jan 25;13(3):439. doi: 10.3390/cancers13030439.
4
Imaging Characterization of Renal Masses.肾脏肿块的影像学特征。
Medicina (Kaunas). 2021 Jan 8;57(1):51. doi: 10.3390/medicina57010051.
5
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.乳腺癌发生和靶向治疗的蛋白质基因组全景分析
Cell. 2020 Nov 25;183(5):1436-1456.e31. doi: 10.1016/j.cell.2020.10.036. Epub 2020 Nov 18.
6
Chromophobe renal cell carcinoma: current and controversial issues.嫌色细胞性肾细胞癌:当前和有争议的问题。
Pathology. 2021 Jan;53(1):101-108. doi: 10.1016/j.pathol.2020.09.015. Epub 2020 Nov 9.
7
Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma.基于DNA甲基化的诊断标志物的开发,用于区分良性嗜酸细胞瘤与肾细胞癌。
JCO Precis Oncol. 2020 Sep 28;4. doi: 10.1200/PO.20.00015. eCollection 2020.
8
Chromophobe renal cell carcinoma: New genetic and metabolic insights.嫌色细胞肾细胞癌:新的遗传学和代谢见解。
Urol Oncol. 2020 Aug;38(8):678-681. doi: 10.1016/j.urolonc.2020.04.035. Epub 2020 May 20.
9
Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning.基于基因表达数据训练的有监督机器学习的浸润性导管癌进展分类模型。
Sci Rep. 2020 Mar 5;10(1):4113. doi: 10.1038/s41598-020-60740-w.
10
Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.基于生物信息学分析鉴定嫌色细胞型肾细胞癌和肾嗜酸细胞瘤的关键基因及预后分析。
Biomed Res Int. 2020 Jan 11;2020:4030915. doi: 10.1155/2020/4030915. eCollection 2020.